A breakthrough advance that turns conventional wisdom on its head could lead to a simple blood test for Alzheimer's, research has shown.
The same technology, successfully tested on human patients, could make it easier to spot hard-to-detect cancers and other diseases.
It involves using synthetic molecules called peptoids to “fish” for disease-specific antibodies in the blood, said Professor Thomas Kodadek, from Scripps Research Institute in California, who led the research.